APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bronchiectasis Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bronchiectasis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025181 pages

Choose your research edition.

Industry ResearchBronchiectasis Drugs Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Bronchiectasis Drugs Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Bronchiectasis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bronchiectasis Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bronchiectasis Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Bronchiectasis Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Bronchiectasis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bronchiectasis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bronchiectasis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bronchiectasis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bronchiectasis Drugs include Pfizer Inc., GlaxoSmithKline Plc, Reckitt Benckiser Group Plc, Neopharma LLC and Endo International Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Bronchiectasis Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bronchiectasis Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bronchiectasis Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Bronchiectasis Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Bronchiectasis Drugs Segment by Company

Pfizer Inc.

GlaxoSmithKline Plc

Reckitt Benckiser Group Plc

Neopharma LLC

Endo International Plc

Bronchiectasis Drugs Segment by Type

Antibiotics

Expectorants

Other drugs

Bronchiectasis Drugs Segment by Application

Research institute

Hospital

Clinic

Other

Bronchiectasis Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bronchiectasis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bronchiectasis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bronchiectasis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Bronchiectasis Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bronchiectasis Drugs industry.

Chapter 3: Detailed analysis of Bronchiectasis Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bronchiectasis Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bronchiectasis Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Antibiotics Table 3. Key Players of Expectorants Table 4. Key Players of Other drugs Table 4. Global Bronchiectasis Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Research institute Table 6. Key Players of Hospital Table 7. Key Players of Clinic Table 8. Key Players of Other Table 9. Global Bronchiectasis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Bronchiectasis Drugs Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Bronchiectasis Drugs Market Share by Region (2021-2026) Table 12. Global Bronchiectasis Drugs Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Bronchiectasis Drugs Market Share by Region (2027-2032) Table 14. Bronchiectasis Drugs Industry Trends Table 15. Bronchiectasis Drugs Industry Drivers Table 16. Bronchiectasis Drugs Industry Opportunities and Challenges Table 17. Bronchiectasis Drugs Industry Restraints Table 18. Global Bronchiectasis Drugs Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Bronchiectasis Drugs Revenue Market Share by Company (2021-2026) Table 20. Global Bronchiectasis Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Bronchiectasis Drugs Key Company Head Office and Area Served Table 22. Global Bronchiectasis Drugs Company, Product Type & Application Table 23. Global Bronchiectasis Drugs Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Bronchiectasis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Bronchiectasis Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Bronchiectasis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Bronchiectasis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Bronchiectasis Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Bronchiectasis Drugs Revenue Market Share by Type (2027-2032) Table 31. Global Bronchiectasis Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Bronchiectasis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Bronchiectasis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Bronchiectasis Drugs Revenue Market Share by Application (2021-2026) Table 35. Global Bronchiectasis Drugs Revenue Market Share by Application (2027-2032) Table 36. Pfizer Inc. Company Information Table 37. Pfizer Inc. Business Overview Table 38. Pfizer Inc. Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Pfizer Inc. Bronchiectasis Drugs Product Portfolio Table 40. Pfizer Inc. Recent Development Table 41. GlaxoSmithKline Plc Company Information Table 42. GlaxoSmithKline Plc Business Overview Table 43. GlaxoSmithKline Plc Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. GlaxoSmithKline Plc Bronchiectasis Drugs Product Portfolio Table 45. GlaxoSmithKline Plc Recent Development Table 46. Reckitt Benckiser Group Plc Company Information Table 47. Reckitt Benckiser Group Plc Business Overview Table 48. Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Portfolio Table 50. Reckitt Benckiser Group Plc Recent Development Table 51. Neopharma LLC Company Information Table 52. Neopharma LLC Business Overview Table 53. Neopharma LLC Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Neopharma LLC Bronchiectasis Drugs Product Portfolio Table 55. Neopharma LLC Recent Development Table 56. Endo International Plc Company Information Table 57. Endo International Plc Business Overview Table 58. Endo International Plc Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Endo International Plc Bronchiectasis Drugs Product Portfolio Table 60. Endo International Plc Recent Development Table 61. North America Bronchiectasis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 62. North America Bronchiectasis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 63. North America Bronchiectasis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 64. North America Bronchiectasis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 65. North America Bronchiectasis Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 66. North America Bronchiectasis Drugs Market Size by Country (2021-2026) Table 67. North America Bronchiectasis Drugs Market Size by Country (2027-2032) Table 68. Europe Bronchiectasis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 69. Europe Bronchiectasis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 70. Europe Bronchiectasis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 71. Europe Bronchiectasis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 72. Europe Bronchiectasis Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Europe Bronchiectasis Drugs Market Size by Country (2021-2026) Table 74. Europe Bronchiectasis Drugs Market Size by Country (2027-2032) Table 75. China Bronchiectasis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 76. China Bronchiectasis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 77. China Bronchiectasis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 78. China Bronchiectasis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 79. Asia Bronchiectasis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 80. Asia Bronchiectasis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 81. Asia Bronchiectasis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 82. Asia Bronchiectasis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Bronchiectasis Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Asia Bronchiectasis Drugs Market Size by Country (2021-2026) Table 85. Asia Bronchiectasis Drugs Market Size by Country (2027-2032) Table 86. South America, Middle East & Africa Bronchiectasis Drugs Market Size by Type (2021-2026) & (US$ Million) Table 87. South America, Middle East & Africa Bronchiectasis Drugs Market Size by Type (2027-2032) & (US$ Million) Table 88. South America, Middle East & Africa Bronchiectasis Drugs Market Size by Application (2021-2026) & (US$ Million) Table 89. South America, Middle East & Africa Bronchiectasis Drugs Market Size by Application (2027-2032) & (US$ Million) Table 90. South America, Middle East & Africa Bronchiectasis Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. South America, Middle East & Africa Bronchiectasis Drugs Market Size by Country (2021-2026) Table 92. South America, Middle East & Africa Bronchiectasis Drugs Market Size by Country (2027-2032) Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Bronchiectasis Drugs Product Image Figure 2. Global Bronchiectasis Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Bronchiectasis Drugs Market Share by Type: 2025 VS 2032 Figure 4. Antibiotics Image Figure 5. Expectorants Image Figure 6. Other drugs Image Figure 7. Global Bronchiectasis Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Bronchiectasis Drugs Market Share by Application: 2025 VS 2032 Figure 9. Research institute Image Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Other Image Figure 13. Global Bronchiectasis Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 15. Global Bronchiectasis Drugs Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Bronchiectasis Drugs Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Bronchiectasis Drugs Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Bronchiectasis Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Bronchiectasis Drugs Revenue Market Share by Type (2021-2032) Figure 22. Global Bronchiectasis Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Bronchiectasis Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 25. North America Bronchiectasis Drugs Market Share by Type (2021-2032) Figure 26. North America Bronchiectasis Drugs Market Share by Application (2021-2032) Figure 27. North America Bronchiectasis Drugs Market Share by Country (2021-2032) Figure 28. United States Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Canada Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Bronchiectasis Drugs Market Share by Type (2021-2032) Figure 33. Europe Bronchiectasis Drugs Market Share by Application (2021-2032) Figure 34. Europe Bronchiectasis Drugs Market Share by Country (2021-2032) Figure 35. Germany Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 36. France Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Italy Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Russia Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Bronchiectasis Drugs Market Share by Type (2021-2032) Figure 43. China Bronchiectasis Drugs Market Share by Application (2021-2032) Figure 44. Asia Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 45. Asia Bronchiectasis Drugs Market Share by Type (2021-2032) Figure 46. Asia Bronchiectasis Drugs Market Share by Application (2021-2032) Figure 47. Asia Bronchiectasis Drugs Market Share by Country (2021-2032) Figure 48. Japan Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 52. India Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Australia Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Bronchiectasis Drugs Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Bronchiectasis Drugs Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Bronchiectasis Drugs Market Share by Country (2021-2032) Figure 58. Brazil Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 63. UAE Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Chile Bronchiectasis Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Expectorants
  • Other drugs
Applications
  • Research institute
  • Hospital
  • Clinic
  • Other
Companies covered
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Reckitt Benckiser Group Plc
  • Neopharma LLC
  • Endo International Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Bronchiectasis Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Antibiotics
  5. 1.2.3 Expectorants
  6. 1.2.4 Other drugs
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Bronchiectasis Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Research institute
  10. 1.3.3 Hospital
  11. 1.3.4 Clinic
  12. 1.3.5 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Bronchiectasis Drugs Growth Trends by Region
  15. 1.5.1 Global Bronchiectasis Drugs Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Bronchiectasis Drugs Market Size by Region (2021-2026)
  17. 1.5.3 Bronchiectasis Drugs Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Bronchiectasis Drugs Market Dynamics
  1. 2.1 Bronchiectasis Drugs Industry Trends
  2. 2.2 Bronchiectasis Drugs Industry Drivers
  3. 2.3 Bronchiectasis Drugs Industry Opportunities and Challenges
  4. 2.4 Bronchiectasis Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Bronchiectasis Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Bronchiectasis Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Bronchiectasis Drugs Key Company Head office and Area Served
  4. 3.4 Global Bronchiectasis Drugs Company, Product Type & Application
  5. 3.5 Global Bronchiectasis Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Bronchiectasis Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Bronchiectasis Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Bronchiectasis Drugs Tier 1, Tier 2, and Tier 3
4 Bronchiectasis Drugs Market by Type
  1. 4.1 Global Bronchiectasis Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Bronchiectasis Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Bronchiectasis Drugs Market Size Share by Type (2021-2032)
5 Bronchiectasis Drugs Market by Application
  1. 5.1 Global Bronchiectasis Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Bronchiectasis Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Bronchiectasis Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Pfizer Inc.
  2. 6.1.1 Pfizer Inc. Company Information
  3. 6.1.2 Pfizer Inc. Business Overview
  4. 6.1.3 Pfizer Inc. Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Pfizer Inc. Bronchiectasis Drugs Product Portfolio
  6. 6.1.5 Pfizer Inc. Recent Developments
  7. 6.2 GlaxoSmithKline Plc
  8. 6.2.1 GlaxoSmithKline Plc Company Information
  9. 6.2.2 GlaxoSmithKline Plc Business Overview
  10. 6.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 GlaxoSmithKline Plc Bronchiectasis Drugs Product Portfolio
  12. 6.2.5 GlaxoSmithKline Plc Recent Developments
  13. 6.3 Reckitt Benckiser Group Plc
  14. 6.3.1 Reckitt Benckiser Group Plc Company Information
  15. 6.3.2 Reckitt Benckiser Group Plc Business Overview
  16. 6.3.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Portfolio
  18. 6.3.5 Reckitt Benckiser Group Plc Recent Developments
  19. 6.4 Neopharma LLC
  20. 6.4.1 Neopharma LLC Company Information
  21. 6.4.2 Neopharma LLC Business Overview
  22. 6.4.3 Neopharma LLC Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Neopharma LLC Bronchiectasis Drugs Product Portfolio
  24. 6.4.5 Neopharma LLC Recent Developments
  25. 6.5 Endo International Plc
  26. 6.5.1 Endo International Plc Company Information
  27. 6.5.2 Endo International Plc Business Overview
  28. 6.5.3 Endo International Plc Bronchiectasis Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Endo International Plc Bronchiectasis Drugs Product Portfolio
  30. 6.5.5 Endo International Plc Recent Developments
7 North America
  1. 7.1 North America Bronchiectasis Drugs Market Size (2021-2032)
  2. 7.2 North America Bronchiectasis Drugs Market Size by Type
  3. 7.2.1 North America Bronchiectasis Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Bronchiectasis Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Bronchiectasis Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Bronchiectasis Drugs Market Size by Application
  7. 7.3.1 North America Bronchiectasis Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Bronchiectasis Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Bronchiectasis Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Bronchiectasis Drugs Market Size by Country
  11. 7.4.1 North America Bronchiectasis Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Bronchiectasis Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Bronchiectasis Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Bronchiectasis Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Bronchiectasis Drugs Market Size (2021-2032)
  2. 8.2 Europe Bronchiectasis Drugs Market Size by Type
  3. 8.2.1 Europe Bronchiectasis Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Bronchiectasis Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Bronchiectasis Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Bronchiectasis Drugs Market Size by Application
  7. 8.3.1 Europe Bronchiectasis Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Bronchiectasis Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Bronchiectasis Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Bronchiectasis Drugs Market Size by Country
  11. 8.4.1 Europe Bronchiectasis Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Bronchiectasis Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Bronchiectasis Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Bronchiectasis Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Bronchiectasis Drugs Market Size (2021-2032)
  2. 9.2 China Bronchiectasis Drugs Market Size by Type
  3. 9.2.1 China Bronchiectasis Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Bronchiectasis Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Bronchiectasis Drugs Market Share by Type (2021-2032)
  6. 9.3 China Bronchiectasis Drugs Market Size by Application
  7. 9.3.1 China Bronchiectasis Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Bronchiectasis Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Bronchiectasis Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Bronchiectasis Drugs Market Size (2021-2032)
  2. 10.2 Asia Bronchiectasis Drugs Market Size by Type
  3. 10.2.1 Asia Bronchiectasis Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Bronchiectasis Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Bronchiectasis Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Bronchiectasis Drugs Market Size by Application
  7. 10.3.1 Asia Bronchiectasis Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Bronchiectasis Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Bronchiectasis Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Bronchiectasis Drugs Market Size by Country
  11. 10.4.1 Asia Bronchiectasis Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Bronchiectasis Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Bronchiectasis Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Bronchiectasis Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Bronchiectasis Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Bronchiectasis Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Bronchiectasis Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Bronchiectasis Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Bronchiectasis Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst